CSIMarket
 


Tarsus Pharmaceuticals Inc   (TARS)
Other Ticker:  
 
 

TARS's Free Cash Flow Growth by Quarter and Year

Tarsus Pharmaceuticals Inc 's Free Cash Flow results by quarter and year




TARS Free Cash Flow (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December -39.34 -10.87 -12.12 -10.01
III Quarter September -32.36 -18.61 7.11 -11.13
II Quarter June -23.83 -4.26 20.55 0.00
I Quarter March -21.97 -15.29 -11.79 0.00
FY   -117.50 -49.03 3.75 -21.14



TARS Free Cash Flow fourth quarter 2023 Y/Y Growth Comment
Tarsus Pharmaceuticals Inc in the fourth quarter 2023 recorded free cash outflow of $ -39.34 millions.

According to the results reported in the fourth quarter 2023, Tarsus Pharmaceuticals Inc achieved the best Free Cash Flow growth in Biotechnology & Pharmaceuticals industry. While Tarsus Pharmaceuticals Inc ' s Free Cash Flow no change of % ranks overall at the positon no. in the fourth quarter 2023.




TARS Free Cash Flow ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Tarsus Pharmaceuticals Inc 's fourth quarter 2023 Free Cash Flow $ -39.34 millions TARS's Income Statement
Tarsus Pharmaceuticals Inc 's fourth quarter 2022 Free Cash Flow $ -10.87 millions Quarterly TARS's Income Statement
New: More TARS's historic Free Cash Flow Growth >>


TARS Free Cash Flow (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - -65.4 % -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Free Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Free Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Free Cash Flow by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Tarsus Pharmaceuticals Inc 's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


TARS's IV. Quarter Q/Q Free Cash Flow Comment
IV. Quarter 2023 accomplishment of -39.34 millions by Tarsus Pharmaceuticals Inc appear even more unfavourable if you take a look at free cash outflow -32.36 millions in the previous quarter.

Within Biotechnology & Pharmaceuticals industry Tarsus Pharmaceuticals Inc achieved highest sequential Free Cash Flow growth. While Tarsus Pharmaceuticals Inc 's Free Cash Flow growth quarter on quarter, overall rank is .


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


TARS's IV. Quarter Q/Q Free Cash Flow Comment
IV. Quarter 2023 free cash outflow of -39.34 millions by Tarsus Pharmaceuticals Inc come out even more unfavourable compare to the -32.36 millions free cash outflow a quarter before.

Within Biotechnology & Pharmaceuticals industry Tarsus Pharmaceuticals Inc achieved highest sequential Free Cash Flow growth. While Tarsus Pharmaceuticals Inc 's Free Cash Flow growth quarter on quarter, overall rank is .


Tarsus Pharmaceuticals Inc 's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Free Cash Flow 12 Months Ending $ -117.49 $ -83.40 $ -73.93 $ -55.03 $ -48.52
Y / Y Free Cash Flow Growth (TTM) - - - - -
Year on Year Free Cash Flow Growth Overall Ranking # # # # #
Seqeuential Free Cash Flow Change (TTM) - - - - -
Seq. Free Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Free Cash Flow growth Comment
Tarsus Pharmaceuticals Inc ' has realized cumulative trailing twelve months free cash outflow of $ -117 millions in the Dec 31 2023 period.
The situation is getting worse as the cumulative free cash outflow is becoming larger from $ -83.4 millions in the twelve months ending a quarter before and $ -49.624 millions for the twelve months ending in the quarter Dec 31 2022.

Tarsus Pharmaceuticals Inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Free Cash Flow growth Comment
Tarsus Pharmaceuticals Inc ' has realized cumulative trailing twelve months free cash outflow of $ -117 millions in the Dec 31 2023 period.
The situation is worsening as the cumulative free cash outflow is inflating from $ -83.4 millions in the twelve months ending a quarter before and $ -49.624 millions from the TTM period ending Dec 31 2022 Lacey  T. Robinson wrote.

Tarsus Pharmaceuticals Inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Free Cash Flow Growth
Biotechnology & Pharmaceuticals Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
TARS's Free Cash Flow Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for TARS's Competitors
Free Cash Flow Growth for Tarsus Pharmaceuticals Inc 's Suppliers
Free Cash Flow Growth for TARS's Customers

You may also want to know
TARS's Annual Growth Rates TARS's Profitability Ratios TARS's Asset Turnover Ratio TARS's Dividend Growth
TARS's Roe TARS's Valuation Ratios TARS's Financial Strength Ratios TARS's Dividend Payout Ratio
TARS's Roa TARS's Inventory Turnover Ratio TARS's Growth Rates TARS's Dividend Comparisons



Companies with similar Free Cash Flow no change for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Dec 31 2023
Tactile Systems Technology Inc 376.06%$ 376.057 millions
Biomarin Pharmaceutical Inc305.00%$ 304.996 millions
Enzon Pharmaceuticals inc 250.00%$ 250.000 millions
Viatris Inc 236.19%$ 236.185 millions
Msa Safety Incorporated196.75%$ 196.747 millions
Livanova Plc188.50%$ 188.499 millions
Harmony Biosciences Holdings inc 187.37%$ 187.372 millions
Nature s Sunshine Products inc 168.40%$ 168.400 millions
Lemaitre Vascular Inc 163.58%$ 163.576 millions
Semler Scientific Inc 159.77%$ 159.766 millions
Electromed Inc 154.47%$ 154.472 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com